Medical Disposables & Supplies Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Kurt Boothe

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	4yrs
Participación del CEO	19.4%
Permanencia media de la dirección	4.1yrs
Promedio de permanencia en la Junta Directiva	10.9yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Kurt Boothe

4yrs

Permanencia

Mr. Kurt Boothe was a Company Secretary and General Manager of Medical Disposables & Supplies Limited until November 01, 2020 and serves as Executive Director. He serves as Chief Executive Officer of Medic...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kurt Boothe	CEO & Executive Director	4yrs	sin datos	19.44% JMD 87.0m
Myrtis Boothe	Founder & Executive Director	no data	sin datos	19% JMD 85.0m
Raymond Ernandez	Chief Financial Officer	no data	sin datos	sin datos
Bertino Gordon	Operations Manager	4.7yrs	sin datos	sin datos
Nadine Banton	Human Resource & Administrative Manager	4.1yrs	sin datos	sin datos
Kandise Morgan-Small	Sales & Marketing Manager	no data	sin datos	sin datos
Nikeisha Hill	Executive Director	no data	sin datos	19% JMD 85.0m

4.1yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de MDS se considera experimentado (4.1 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kurt Boothe	CEO & Executive Director	no data	sin datos	19.44% JMD 87.0m
Myrtis Boothe	Founder & Executive Director	no data	sin datos	19% JMD 85.0m
Nikeisha Hill	Executive Director	no data	sin datos	19% JMD 85.0m
Vincent Lawrence	Lead Independent Director	10.9yrs	JA$613.75k	sin datos
Sheree Martin	Director	less than a year	sin datos	sin datos
Winston Boothe	Chairman	no data	JA$713.75k	19% JMD 85.0m
Dahlia McDaniel-Dickson	Independent Non-Executive Director	10.9yrs	JA$643.75k	0.55% JMD 2.5m

10.9yrs

Permanencia media

Junta con experiencia: Los miembros de la junta directiva de MDS son experimentados ( 10.9 años antigüedad media).

Medical Disposables & Supplies Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Medical Disposables & Supplies Limited Announces Board Appointments

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Second quarter 2025 earnings released: JA$0.16 loss per share (vs JA$0.10 loss in 2Q 2024)

Medical Disposables & Supplies Limited to Report Fiscal Year 2024 Final Results on Nov 29, 2024

Medical Disposables & Supplies Limited Announces Board Appointments

Full year 2024 earnings released: JA$1.11 loss per share (vs JA$0.27 profit in FY 2023)

New minor risk - Share price stability

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Third quarter 2024 earnings released: JA$0.19 loss per share (vs JA$0.11 profit in 3Q 2023)

New major risk - Share price stability

Second quarter 2024 earnings released: JA$0.15 loss per share (vs JA$0.07 profit in 2Q 2023)

Investor sentiment deteriorates as stock falls 24%

First quarter 2024 earnings released: JA$0.01 loss per share (vs JA$0.06 profit in 1Q 2023)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 17%

Full year 2023 earnings released: EPS: JA$0.27 (vs JA$0.37 in FY 2022)

Investor sentiment improves as stock rises 22%

Third quarter 2023 earnings released: EPS: JA$0.11 (vs JA$0.11 in 3Q 2022)

Investor sentiment improves as stock rises 18%

Investor sentiment improved over the past week

Upcoming dividend of JA$0.09 per share

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: JA$0.37 (vs JA$0.27 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of JA$0.07 per share

First quarter 2022 earnings released: EPS JA$0.10 (vs JA$0.03 loss in 1Q 2021)

Full year 2021 earnings released

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: JA$4.74

Third quarter 2021 earnings released: EPS JA$0.10 (vs JA$0.02 in 3Q 2020)

Second quarter 2021 earnings released: JA$0.02 loss per share

Market pulls back on stock over the past week

New 90-day low: JA$4.30

New 90-day low - JA$4.67

First quarter earnings released

New 90-day low - JA$5.07

CEO

Permanencia

Equipo directivo

Permanencia media

Miembros de la Junta

Permanencia media